Domo, Inc.
NASDAQ:DOMOSoftware - Application
+$0.43 today
- Market cap
- $155.39M
- Beta
- 1.77
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$1.28
Volume 3.18M
Average 1.39M
DOMO Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Domo, Inc.NASDAQ: DOMO
Accounts Payables · Q1 FY2027 · quarter ended Apr 2026
Accounts payables dips below year-ago levels
Q1 FY2027 accounts payables of $3.07M fell 8.6% year over year, behind the +674.8% change in trailing-twelve-month accounts payables. Over 3 fiscal years it compounded at +8.5% a year.
Context
- Accounts payables amounted to 2.8% of revenue in FY2026, up 2.2 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -8.6% toward the trailing-twelve-month pace of +674.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2026
- 8.88M USD
- Year-over-year change
- +385.6%
- 4-year CAGR
- +24.0%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 8.88M | +385.6% |
| FY2025 | 2025-01-31 | 1.83M | +126.2% |
| FY2024 | 2024-01-31 | (6.97M) | -200.4% |
| FY2023 | 2023-01-31 | 6.95M | +85.0% |
| FY2022 | 2022-01-31 | 3.76M | — |
Accounts Payables vs competitors
How DOMO compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +674.8% is the 2nd highest of 9, against a peer median of +65.1%.
- Accounts payables amounts to 2.7% of revenue for DOMO, versus a peer median of 1.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $10.55M USD | -2128.3% | +51.4% | 26.1% | |
| LTM Apr 2026 | $8.59M USD | +674.8% | +8.5% | 2.7% | |
| LTM Mar 2026 | $7.18M USD | -87.0% | — | 1.3% | |
| LTM Mar 2026 | $6.27M USD | — | — | 1.3% | |
| FY2025 | $6.01M USD | +21.5% | — | 1133.4% | |
| LTM Mar 2026 | $2.9M USD | -15.4% | — | 0.3% | |
| LTM Mar 2026 | $1.93M USD | +843.2% | +7.5% | 2.0% | |
| LTM Mar 2026 | $1.7M USD | +254.1% | +49.0% | 0.7% | |
| LTM Mar 2026 | $847K USD | +108.7% | — | 0.3% | |
| LTM Mar 2026 | $314K USD | +184.4% | -37.3% | 0.2% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥0 CNY | — | — | — |
| Peer median (excluding DOMO) | — | +65.1% | +28.2% | 1.3% | |
Competitors are the stored peer set for DOMO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | (102.11M) | (105.55M) | (75.57M) | (81.94M) | (59.34M) |
| Depreciation & Amortization | 10.2M | 10.02M | 24.39M | 26.76M | 9.84M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 56.06M |
| Change in Working Capital | 12.31M | (22.93M) | (19.64M) | (25.85M) | (23.52M) |
| Accounts Receivables | (15.88M) | (14.81M) | 11.76M | (4.35M) | (13.91M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 3.76M | 6.95M | (6.97M) | 1.83M | 8.88M |
| Other Working Capital | 24.43M | (15.06M) | (24.43M) | (23.33M) | (18.49M) |
| Other Non-Cash Items | 79.98M | 107.57M | 73.4M | 71.97M | 24.9M |
| Operating Cash Flow | 379K | (10.89M) | 2.58M | (9.05M) | 7.93M |
| Capital Expenditures | (6.52M) | (8M) | (11.73M) | (9.45M) | (9.95M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (6.52M) | (8M) | (11.76M) | (9.45M) | (9.95M) |
| Debt Repayment | 0 | 0 | 0 | 3.3M | (6.79M) |
| Common Stock Issued | 9.75M | 2.42M | 3.47M | 1.91M | 1.33M |
| Common Stock Repurchased | (10.32M) | 0 | 0 | (820K) | (3.25M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | (1M) | 6.5M |
| Financing Cash Flow | (561K) | 2.42M | 3.47M | 3.39M | (2.2M) |
| Effect of Forex Changes | (534K) | (599K) | 145K | (569K) | 1.91M |
| Net Change in Cash | (7.23M) | (17.06M) | (5.56M) | (15.68M) | (2.31M) |
| Free Cash Flow | (6.14M) | (18.89M) | (9.15M) | (18.5M) | (2.02M) |
Domo, Inc.
NASDAQ:DOMO
Intrinsic Alpha fair value
Locked
Current Price
$3.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.